Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol to Describe the Actual Situation of Hepatitis C Treatment in Brazil

NCT02773394 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd. as lead sponsor.

NCT NCT02773394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02773394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol to Describe the Actual Situation of Hepatitis C Treatment in Brazil
Lead sponsor
Janssen-Cilag Ltd.
Phase
Observational
Overall status
Completed
Start date
April 12, 2016
Completion date
November 30, 2016
Enrollment
1,649 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus